Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · IEX Real-Time Price · USD

2.450

-0.120 (-4.67%)

At close: Jul 19, 2024, 4:00 PM

2.050

-0.400 (-16.33%)

Pre-market: Jul 22, 2024, 4:21 AM EDT

Vivos Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Vivos Therapeutics.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for VVOS.

Recommendation Trends

Rating	Aug '22	Sep '22	Oct '22	Nov '22	Dec '22
Strong Buy	2	2	2	2	2
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Initiates $63	Strong Buy	Initiates	$63	+2,451.02%	Jan 17, 2023
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $275 → $250	Strong Buy	Maintains	$275 → $250	+10,104.08%	Aug 13, 2021
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $300 → $275	Strong Buy	Maintains	$300 → $275	+11,124.49%	May 18, 2021
Alexander Nowak Craig-Hallum	Craig-Hallum	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+12,144.90%	Jan 11, 2021
Scott Henry Roth Capital	Roth Capital	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+12,144.90%	Jan 5, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

15.76M

from 13.80M

14.17%

from 13.80M

Revenue Next Year

18.78M

from 15.76M

19.16%

from 15.76M

EPS This Year

-3.56

from -11.14

EPS Next Year

-2.31

from -3.56

Year	2019	2020	2021	2022	2023	2024	2025
Revenue	11.39M	13.07M	16.89M	16.02M	13.80M	15.76M	18.78M
Revenue Growth	200.43%	14.68%	29.23%	-5.10%	-13.87%	14.17%	19.16%
EPS	-23.75	-35.00	-24.00	-25.90	-11.14	-3.56	-2.31
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025
High	16.8M	20.2M
Avg	15.8M	18.8M
Low	14.6M	17.2M

Revenue Growth

Revenue Growth	2024	2025
High	21.7%	28.0%
Avg	14.2%	19.2%
Low	5.8%	9.5%

EPS Forecast

EPS	2024	2025
High	-2.99	-1.58
Avg	-3.56	-2.31
Low	-4.06	-2.96

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.